New York, United States – The European Union has purchased 300 Million Covid-19 vaccine doses from the ground-breaking coronavirus vaccine developed with the collaboration of BioNTech and Pfizer.
According to the pharmaceutical corporation, Pfizer and their German partner, BioNTech, the Covid-19 vaccine they made has achieved 90% success in preventing COVID-19. This result came from the first interim analysis they did for a study of phase 3.
Media outlet, Al Jazeera revealed that the EU made a deal which ensures that the 27 countries in EU can buy 200 million doses and will have an option to purchase another 100 million along with it.
While the EU officials and Pfizer and BioNTech refused to give detailed information of the price of the vaccine, an EU official informed that EU had agreed to a price closer to $20 per jab than to $10 per jab. This official also refrained from giving a precise figure. Another official of EU informed that they will be paying less than $19.50 per jab.
The President of the EU’s Executive Arm, Ursula von der Leyen commented regarding the vaccine saying that it is “the most promising vaccine so far” and that as soon as the union gets ahold of the vaccine, they plan to deploy it to everywhere in Europe as fast as they can.
She further stated that vulnerable groups such as the healthcare workers and people over 60 years, as well as people with health conditions will be given the most priority while giving the vaccines.
In addition to this vaccine, the EU has secured three other deals with different pharmaceutical companies as “they need to have a broad portfolio of vaccines based on different technologies,” according to von der Leyen.